Antengene unveils three pipeline programs at AACR 2026 as AnTenGager platform expands beyond UCB deal
Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
Read More Healthcare Industry News Elanco (NYSE: ELAN) stock gains as FDA grants emergency use for Credelio CAT to combat New World screwworm in cats Elanco stock jumps 4.76% as FDA approves Credelio CAT for emergency screwworm use. Find out what this means for feline health and investor momentum. bySrinathNovember 21, 2025